Clinical Trial Update: Pucotenlimab Combined With Lenvatinib and Chemotherapy in the Treatment of Advanced, Relapsed/Refractory Hepatoblastoma in Children [NA]

View source ↗

Summary

A clinical trial update announcing a study evaluating pucotenlimab in combination with lenvatinib and chemotherapy for advanced, relapsed/refractory hepatoblast…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatoblastoma

Drugs mentioned

• LENVIMA (lenvatinib)
• Pucotenlimab

Snippet

Sponsor: Sun Yat-sen University | Conditions: Hepatoblastoma, Pediatric Cancer | NA | Status: RECRUITING